Replies to post #5267 on Biotech Values

[poorgradstudent]

>BIOM - Their drug would be used after chemo so not a competitor to YMI<

I wasn't mentioning Theratope as a possible competitor. Rather as a drug that showed a doubling of median survival in phase II.